Strides gets FDA approval for HIV drug

NEW DELHI: Drug firm Stride Arcolab has received a tentative approval from US health regulator Food and Drug Administration (FDA) for generic drug abacavir sulfate tablets, which are used against HIV infection.

According to the information on the regulator's website, the Indian firm has got the approval for the generic version of the tablets in 300 mg strengths.

Shares of Strides Arcolab were trading at Rs 331 in afternoon trade at Bombay Stock Exchange, down 3.17 percent from its previous close.